TrialAntimicrobial agents and chemotherapy2004

Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Anne Schmitt-Hoffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.